Skin cancer patients find hope. Two new life-extending drugs may be made available to people with an advanced form of skin cancer in the UK.From:WorldWideNewssViews:0 0ratingsTime:00:18More inNews Politics Read the original post: Skin cancer patients find hope. - Video … Continue reading →

Filagra 100 mg Filagra 100 mg is one of the best amongst the premium low cost ED drugs.From:rxChemistryViews:0 0ratingsTime:01:01More inHowto Style Read the original post: Filagra 100 mg - Video … Continue reading →

Pauly Shore on sex, drugs and politics Pauly Shore sits down in the CNN Red Chair to talk about sex, drugs and his new Showtime special, "Pauly-tics."From:kubat otuzşubatViews:0 0ratingsTime:03:46More inPeople Blogs Read more: Pauly Shore on sex, drugs and politics - Video … Continue reading →

Big Drug Racket busted in Kukutpally 3 Software engneers Saleing Drugs This Video Created by Ntv Telugu News ChannelFrom:TheTelugutouchnewsViews:0 0ratingsTime:01:28More inNews Politics Here is the original post: Big Drug Racket busted in Kukutpally 3 Software engneers Saleing Drugs - Video … Continue reading →

LONDON (Reuters) - Two new drugs for skin cancer have been recommended for use on Britain's state-run health service after the rival manufacturers - Roche and Bristol-Myers Squibb - agreed to cut their prices. The move underscores the growing pressure on drug companies to cut deals with austerity-hit European governments in order to prove their expensive new medicines offer value for money. The National Institute for Health and Clinical Excellence (NICE) said on Friday it had issued final draft guidance recommending both Roche's Zelboraf and Bristol's Yervoy after the companies offered undisclosed discounts. NICE, which determines if products should be used by the National Health Service (NHS), had initially rejected both medicines, despite acknowledging that they represented a breakthrough in treating melanoma. The list price for Zelboraf, which is only suitable for patients with a particular genetic profile, is 52,500 pounds ($84,600) for an average treatment span of seven months. The price of a four-dose course of Yervoy, which is recommended only for people who have received prior chemotherapy, is 75,000 pounds. ($1 = 0.6207 British pounds) (Reporting by Ben Hirschler; Editing by Mark Potter) See the article here: UK cost agency backs melanoma drugs after price cuts … Continue reading →

Drugs courier Justin Cook made trips across the Pennines 8:19am Friday 2nd November 2012 in News By Megi Rychlikova, megi.rychlikova@thepress.co.uk A DRUGS courier has been jailed after he was stopped on the outskirts of York with cocaine and cannabis worth thousands of pounds in his car. Justin Cook was part of a supply chain delivering cocaine across the Pennines to North Yorkshire, York Crown Court heard. Christopher Attwooll, prosecuting, said Cook initially pretended he knew nothing of the 28.2g of cocaine a specially-trained police dog found in the back pocket of the front passenger seat, or the 13.5g cocaine found in the back of the drivers seat, when he was stopped on the A64 at Stockton-on-the-Forest in February last year. Both caches had a high level of purity. Together with 248g of herbal cannabis, which he immediately handed over to police, the drugs were worth up to 8,040 if the cocaine was split up, mixed with other substances and sold as street deals. Judge Stephen Ashurst, the Recorder of York, told Cook: You knew in February last year what a risk you were running if you were caught. People who involve themselves in the chain of drugs supply have to … Continue reading →

Hamilton's Police commander is crediting a combination of officers following their instincts backed up with new, more effective legislation for the arrest of a man and the recovery of an assault rifle and drugs during a routine traffic stop overnight. Inspector Greg Nicholls said the car was the subject of a routine traffic stop after officers became concerned about the driving of a man travelling west on Norton Rd about 10.30pm. "The car was pulled over on Rua St and the 35-year-old driver spoken to. "A subsequent search under the recently introduced Search and Surveillance Act resulted in the recovery of two containers of what is believed to be methamphetamine, a bag of yet to be identified pills, some scales and some chemicals." But it was what was found next that Police found to be the most concerning. "Officers searching the car discovered one 5.56 calibre M4 type, scoped assault rifle, a high capacity magazine and a large box containing several packets of ammunition. In addition two electric soft air BB type rifles were also found that if pointed at someone would certainly appear authentic. "There are a number of things these discoveries highlight to us and one of those … Continue reading →

LONDON (Reuters) - Two new drugs for skin cancer have been recommended for use on Britain's state-run health service after the rival manufacturers - Roche and Bristol-Myers Squibb - agreed to cut their prices. The move underscores the growing pressure on drug companies to cut deals with austerity-hit European governments in order to prove their expensive new medicines offer value for money. The National Institute for Health and Clinical Excellence (NICE) said on Friday it had issued final draft guidance recommending both Roche's Zelboraf and Bristol's Yervoy after the companies offered undisclosed discounts. NICE, which determines if products should be used by the National Health Service (NHS), had initially rejected both medicines, despite acknowledging that they represented a breakthrough in treating melanoma. The list price for Zelboraf, which is only suitable for patients with a particular genetic profile, is 52,500 pounds for an average treatment span of seven months. The price of a four-dose course of Yervoy, which is recommended only for people who have received prior chemotherapy, is 75,000 pounds. (Reporting by Ben Hirschler; Editing by Mark Potter) View post: NICE backs melanoma drugs after price cuts … Continue reading →

By Daniel J. DeNoon WebMD Health News Reviewed by Louise Chang, MD Nov. 1, 2012 -- Two more drugs made by the New England Compounding Center (NECC) are crawling with various kinds of bacteria, FDA tests reveal. The NECC is the Massachusetts compounding pharmacy whose drugs are the likely source of the ongoing outbreak of fungal meningitis. The FDA previously found fungus growing in unopened vials of the company's methylprednisolone injectable steroid. Now the FDA has found bacteria in three lots of the NECC's betamethasone, another injectable steroid, and in cardioplegia solution, a drug used to stop the heart during transplant operations. It's not yet clear whether the drugs also carry fungal contamination or other kinds of bacteria. Tests of each lot of the drugs found a different combination of bacteria: Two of these bacteria -- Bacillus idriensis and Bacillus circulans -- have been linked to rare cases of human disease. The FDA says that for patients treated with these drugs, "the clinical significance of these results is not known." All NECC drugs were recalled on Oct. 6. The FDA has not estimated how many patients were treated with the contaminated betamethasone or cardioplegia solution before that date. So far, … Continue reading →

(Reuters) - Health regulators will delay decisions on some drugs for up to two days because of the massive storm Sandy, which closed the federal government. The Food and Drug Administration said on Friday that the delay in meeting regulatory timelines for prescription drugs, medical devices and biosimilar drugs would apply to those with target dates around October 29 and 30, when offices were closed. For those drugs with target dates on October 31 or later, the agency will consider whether a delay is warranted, but it will not exceed two days. Sandy hit the East Coast late on Monday. The U.S. government closed ahead of the storm, and again on Tuesday due to widespread power outages and transit issues. The FDA has set times to review drugs under a user fee program that manufacturers help fund in return for the agency's meeting certain performance goals. For instance, it must review a certain percentage of drug applications within a set time. New drug application target approval dates under the Prescription Drug User Fee Act, or PDUFA, are closely watched because they indicate when companies will be able to start selling their new products. The Biosimilar User Fee Act - which … Continue reading →